Results 161 to 170 of about 10,714 (176)

SHP2 INHIBITOR MONOTHERAPY AND USES THEREOF

2022
SHOJAEI FARBOD, RICONO JILL M, GOODENOW ROBERT, GILLINGS MIREILLE   +3 more
openaire   +4 more sources

COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2

2016
BAGDANOFF JEFFREY T, CHEN ZHUOLIANG, DORE MICHAEL, FORTANET JORGE GARCIA, KATO MITSUNORI, LAMARCHE MATTHEW J, SARVER PATRICK JAMES, SHULTZ MICHAEL, SMITH TROY DOUGLAS, WILLIAMS SARAH   +9 more
openaire   +3 more sources

Compounds and compositions for inhibiting the activity of SHP2

2016
CHEN ZHUOLIANG, JORGE FARCIA FORTANET, MATTHEW J LAMARCHE, MARTIN SENDZIK, VICTORIANO TAMEZ JR, YU BING   +5 more
openaire   +4 more sources

HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2

2022
SHIMAMURA TADASHI, KATO RYO, MIURA RISAKO, MITA TAKASHI, OGAWA TAKAHIRO, SAGARA YUFU, JOHNSON CHRISTOPHER NORBERT, HOWARD STEVEN, DAY JAMES EDWARD HARVEY, ST DENIS JEFFREY DAVID, LIEBESCHUETZ JOHN WALTER   +10 more
openaire   +2 more sources

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells

Cell Death and Differentiation, 2008
exaly  

SHP2 INHIBITORS AND METHODS OF TREATING AUTOIMMUNE AND/OR GLOMERULONEPHRITIS-ASSOCIATED DISEASES USING SHP2 INHIBITORS

2017
ZHANG ZHONG-YIN, KONTARIDIS MARIA, ZENG LI-FAN, WANG JIANXUN   +3 more
openaire   +2 more sources

Targeting SHP2 Signaling in Lung Cancer

Journal of Thoracic Oncology
Denis Imbody, Keishla Arce, Hitendra S. Solanki, Eric B. Haura, Bruna Pellini   +4 more
openaire   +2 more sources

Compounds and compositions for inhibiting the activity of SHP2

2019
TOURE BAKARY-BARRY, CHEN ZHUOLIANG, FORTANET JORGE GARCIA, JOUK ANDRIANA, KARKI RAJESH, LAMARCHE MATTHEW J, LIU GANG, PALERMO MARK G, PEREZ LAWRENCE BLAS, SARVER PATRICK JAMES, SHULTZ MICHAEL DAVID, YU BING, SENDZIK MARTIN   +12 more
openaire   +2 more sources

Pyridine compounds as allosteric SHP2 inhibitors

2018
GILL ADRIAN, AAY NAING, MELLEM KEVIN, BUCKL ANDREAS, KOLTUN ELENA S, SEMKO CHRISTOPHER, KISS GERT   +6 more
openaire   +5 more sources

Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules

European Journal of Medicinal Chemistry
Jinyi Xu, Shengtao Xu, Duan Yiping
exaly